mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for DPYS
Gene summary
Basic gene Info.Gene symbolDPYS
Gene namedihydropyrimidinase
SynonymsDHP|DHPase
CytomapUCSC genome browser: 8q22
Type of geneprotein-coding
RefGenesNM_001385.2,
Descriptiondihydropyrimidine amidohydrolasehydantoinase
Modification date20141207
dbXrefs MIM : 613326
HGNC : HGNC
Ensembl : ENSG00000147647
HPRD : 01960
Vega : OTTHUMG00000164891
ProteinUniProt: Q14117
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_DPYS
BioGPS: 1807
PathwayNCI Pathway Interaction Database: DPYS
KEGG: DPYS
REACTOME: DPYS
Pathway Commons: DPYS
ContextiHOP: DPYS
ligand binding site mutation search in PubMed: DPYS
UCL Cancer Institute: DPYS
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0006208pyrimidine nucleobase catabolic process9718352
GO:0006212uracil catabolic process10410956


Top
Ligand binding site mutations for DPYS
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
H192V191ACOAD1
H192Q190HCOAD1
K159K159NCOAD1
H248M250ISKCM1
D326G324ESKCM1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for DPYS
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
K159K159N-1.4941453
H192V191A-0.92354985
H248M250I-0.88920274
H192Q190H-0.69615078
D326G324E-0.38672481
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for DPYS from PDB

Top
Differential gene expression and gene-gene network for DPYS
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of DPYS and the right PPI network was created from samples without mutations in the LBS of DPYS. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for DPYS
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0342803Dihydropyrimidinase Deficiency1Biomarker, GeneticVariation

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for DPYS
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of DPYS go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
ZNZINC(2+)2vr2AK159 D326
ZNZINC(2+)2vr2AK159 H192 H248


Top
Conservation information for LBS of DPYS
Multiple alignments for Q14117 in multiple species
LBSAA sequence# speciesSpecies
D326TTTGSDNCTFN2Mus musculus, Rattus norvegicus
D326TTTGTDNCTFN1Homo sapiens
D326QLVGTDHCTFN1Arabidopsis thaliana
D326HLTGTDNCTYD1Caenorhabditis elegans
D326HLTATDNCTFD1Caenorhabditis elegans
H192AIAQVHAENGD3Homo sapiens, Mus musculus, Rattus norvegicus
H192ALAMVHAENGD1Arabidopsis thaliana
H192ALARVHCENGS1Caenorhabditis elegans
H192ALARVHAENGS1Caenorhabditis elegans
H248PLYIVHVMSKS2Homo sapiens, Rattus norvegicus
H248PLYVVHVMSVD1Arabidopsis thaliana
H248PLYVVHVMSKS1Mus musculus
H248PVYIVHVMTKG1Caenorhabditis elegans
H248PLYVVHVMSKG1Caenorhabditis elegans
H67GGIDTHTHMQF3Homo sapiens, Mus musculus, Rattus norvegicus
H67GGIDPHTHLAM1Arabidopsis thaliana
H67GGIDPHTHMQM1Caenorhabditis elegans
H67GGIDPHTHMQL1Caenorhabditis elegans
H69IDTHTHMQFPF3Homo sapiens, Mus musculus, Rattus norvegicus
H69IDPHTHLAMEF1Arabidopsis thaliana
H69IDPHTHMQMPY1Caenorhabditis elegans
H69IDPHTHMQLPF1Caenorhabditis elegans
K159GVNSFKMFMAY3Homo sapiens, Mus musculus, Rattus norvegicus
K159GINSFKFFLAY2Arabidopsis thaliana, Caenorhabditis elegans
K159GVNSFKFYMAY1Caenorhabditis elegans


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas